Advanced Enzyme Technologies Limited has released its Earnings Presentation for the quarter and half-year ended September 30, 2026. The document outlines the company’s performance across various segments including Human Nutrition, Animal Nutrition, Industrial Bio-processing, and Specialized Manufacturing. It also details financial summaries, geographical performance, and future growth drivers, offering a comprehensive overview of the company’s operational and strategic landscape.
Advanced Enzyme Technologies Presents Q2 FY27 Earnings
Advanced Enzyme Technologies Limited has issued its Earnings Presentation for the quarter and half-year ended September 30, 2026. This comprehensive document details the company’s financial performance, strategic focus, and operational highlights.
Financial Performance Summary
The presentation includes a summary of the company’s results for Q2 FY27, showcasing year-on-year growth. Revenue grew by 16% to ₹ 2,145 million, EBITDA increased by 20% to ₹ 721 million, and PAT rose by 14% to ₹ 512 million compared to the previous year.
Quarter-on-Quarter (Q-o-Q) performance for Q2 FY27 also showed positive trends, with Revenue up 12%, EBITDA up 36%, and PAT up 33%. The first half (H1 FY27) Year-to-Date (YTD) results indicated a 10% growth in Revenue, a 7% increase in EBITDA, and a 5% rise in PAT.
Segmental Performance
The company highlighted performance across its key business segments:
- Human Nutrition: Contributed 60% of sales, with a 6% growth in Q2 FY27 over Q2 FY26.
- Animal Nutrition: Contributed 12% of sales, showing a significant 37% growth in Q2 FY27 over Q2 FY26.
- Industrial Bio-processing: Contributed 17% of sales, with a strong 43% YoY growth in Q2 FY27.
- Specialized Manufacturing: Contributed 11% of sales, outperforming by 25% on a YoY basis in Q2 FY27.
Geographical Performance
The presentation detailed the geographical performance for Q2 FY27 and H1 FY27. India remained the largest contributor at 52% of Q2 FY27 sales, showing a 25% increase. Americas contributed 27% with a 4% growth, while Asia and Rest of the World also showed positive growth trends.
Future Growth Drivers
Advanced Enzyme Technologies plans to drive future growth through:
- Continued Investment in R&D: Focusing on product gaps and developing new enzymes, probiotics, and solutions.
- Broaden & Deepen Geographical Presence: Increasing focus on high-return applications and building strategic partnerships.
- Inorganic Expansion: Through acquisition of key technologies, competencies, and client relationships.
Focus Areas
Key focus areas for the company moving forward include Animal Nutrition, Probiotics, Bio-Catalysis, and Baking Solutions, aiming to leverage market opportunities and expand its product offerings and reach.
Source: BSE
